Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Introduction to Fibroblasts01:09

Introduction to Fibroblasts

3.1K
Rudolph Virchow discovered spindle-shaped cells called fibroblasts in 1858. Inactive fibroblasts, called fibrocytes, become activated by various stimuli, such as growth factors and inflammatory cytokines. Activated fibroblasts play a crucial role in wound healing, inflammation, formation of new blood vessels, and cancer progression. Uncontrolled activation of fibroblasts results in fibrosis, the excess deposition of fibrous tissue, which can lead to scarring and affect normal organs. This...
3.1K
  1. Home
  2. Research Domains
  3. Biomedical And Clinical Sciences
  4. Oncology And Carcinogenesis
  5. Predictive And Prognostic Markers
  6. Determination Of Permissive And Restraining Cancer-associated Fibroblast (decaf) Subtypes.

Determination of permissive and restraining cancer-associated fibroblast (DeCAF) subtypes.

Xianlu Laura Peng, Elena V Kharitonova, Yi Xu

    Biorxiv : the Preprint Server for Biology
    |May 27, 2024

    Related Experiment Videos

    Murine Dermal Fibroblast Isolation by FACS
    06:04

    Murine Dermal Fibroblast Isolation by FACS

    Published on: January 7, 2016

    21.1K
    Isolation of Normal and Cancer-associated Fibroblasts from Fresh Tissues by Fluorescence Activated Cell Sorting FACS
    11:31

    Isolation of Normal and Cancer-associated Fibroblasts from Fresh Tissues by Fluorescence Activated Cell Sorting FACS

    Published on: January 14, 2013

    35.8K
    Isolation of Primary Cancer-Associated Fibroblasts from a Syngeneic Murine Model of Breast Cancer for the Study of Targeted Nanoparticles
    08:02

    Isolation of Primary Cancer-Associated Fibroblasts from a Syngeneic Murine Model of Breast Cancer for the Study of Targeted Nanoparticles

    Published on: May 14, 2021

    5.6K

    View abstract on PubMed

    Summary
    This summary is machine-generated.

    A new classifier, DeCAF, distinguishes cancer-associated fibroblast (CAF) subtypes in patients. This tool predicts patient outcomes and treatment responses across multiple cancer types, aiding targeted therapy development.

    Area of Science:

    • Oncology
    • Immunology
    • Bioinformatics

    Background:

    • Cancer-associated fibroblasts (CAFs) are crucial in tumor microenvironments, but their subtypes and clinical relevance are not fully understood.
    • Single-cell RNA sequencing (scRNAseq) has identified diverse CAF subpopulations in pancreatic ductal adenocarcinoma (PDAC), yet translating these findings to clinical application is challenging.

    Purpose of the Study:

    • To develop a robust and clinically applicable classifier for distinguishing between cancer-restraining and cancer-permissive CAF subtypes.
    • To investigate the clinical relevance, prognostic value, and predictive capacity of these CAF subtypes across various cancer types.

    Main Methods:

    • Translating scRNAseq-derived CAF marker genes into bulk RNA sequencing data.
    • Developing and validating a single-sample classifier, DeCAF, using 19 independent transcriptomic datasets from PDAC, mesothelioma, bladder, and renal cell carcinoma.

    Related Experiment Videos

    Murine Dermal Fibroblast Isolation by FACS
    06:04

    Murine Dermal Fibroblast Isolation by FACS

    Published on: January 7, 2016

    21.1K
    Isolation of Normal and Cancer-associated Fibroblasts from Fresh Tissues by Fluorescence Activated Cell Sorting FACS
    11:31

    Isolation of Normal and Cancer-associated Fibroblasts from Fresh Tissues by Fluorescence Activated Cell Sorting FACS

    Published on: January 14, 2013

    35.8K
    Isolation of Primary Cancer-Associated Fibroblasts from a Syngeneic Murine Model of Breast Cancer for the Study of Targeted Nanoparticles
    08:02

    Isolation of Primary Cancer-Associated Fibroblasts from a Syngeneic Murine Model of Breast Cancer for the Study of Targeted Nanoparticles

    Published on: May 14, 2021

    5.6K
  • Analyzing associations between DeCAF-defined CAF subtypes and histological features, immune landscapes, patient prognosis, and treatment response.
  • Main Results:

    • DeCAF successfully classifies CAF subtypes across multiple cancer types, demonstrating clinical replicability and robustness.
    • DeCAF-defined CAF subtypes exhibit distinct histological features and immune microenvironments.
    • CAF subtypes classified by DeCAF are prognostic and predict response to therapy, highlighting their clinical significance.

    Conclusions:

    • DeCAF provides a validated framework for classifying CAF subtypes in patients across diverse cancer types.
    • This classification enables a better understanding of the distinct roles of CAF subtypes in cancer progression and treatment response.
    • DeCAF facilitates the development of targeted therapies aimed at modulating CAF functions, either by targeting permissive CAFs or preserving restraining CAFs.